Osimertinib Mesylate | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Osimertinib Mesylate
U.S. EXCLUSIVITIES

PharmaCompass Sponsored Ads

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Osimertinib Mesylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 4 USDMF, 4 EU WC, 6 KDMF, 5 NDC API, 20 Listed Suppliers, $ API Reference Price

24 API Suppliers
4 USDMF
4 EU WC
6 KDMF
5 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

58 Drugs in Development

58 Drugs in Development

INTERMEDIATES

43 Intermediates Suppliers

43 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers, 4 FDA Orange Book, 6 Europe, 2 Canada, 6 Australia, 2 South Africa, 6 Listed Dossiers

26 FDF Dossiers
4 FDA Orange Book
6 Europe
2 Canada
6 Australia
2 South Africa
6 Listed Dossiers

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 3 STOCK RECAP #PipelineProspector, 144 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
3 STOCK RECAP #PipelineProspector
144 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices, 9 Annual Reports

1 US Medicaid Prescriptions
4 Finished Drug Prices
9 Annual Reports

MARKET PLACE

7 APIs, 2 FDF Dossiers

7 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents, 6 US Exclusivities, 2 Health Canada Patents

26 US Patents
6 US Exclusivities
2 Health Canada Patents

$ API Ref.Price (USD/KG) : 14,327 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

6 All

01 6ASTRAZENECA

filter Product Reset all filters

6 All

01 6OSIMERTINIB MESYLATE

filter Exclusivity Expiration Date Reset all filters

6 All

01 22025-04-18

02 22027-02-16

03 22027-12-18

filter Exclusivity Code Reset all filters

6 All

01 2I-941

02 2ODE-176

03 2ODE-337

Egis Osimertinib Mesylate

Product Main Page

ASTRAZENECA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

OSIMERTINIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-337

Exclusivity Expiration Date

2027-12-18

Application Number

208065

Product Number

1

Exclusivity Details

01

ASTRAZENECA

OSIMERTINIB MESYLATE

Fi Europe 2024

Not Confirmed

ASTRAZENECA

United Kingdom

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

OSIMERTINIB MESYLATE

Exclusivity Code : ODE-337

Exclusivity Expiration Date : 2027-12-18

Application Number : 208065

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

OSIMERTINIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-176

Exclusivity Expiration Date

2025-04-18

Application Number

208065

Product Number

1

Exclusivity Details

02

ASTRAZENECA

OSIMERTINIB MESYLATE

Fi Europe 2024

Not Confirmed

ASTRAZENECA

United Kingdom

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

OSIMERTINIB MESYLATE

Exclusivity Code : ODE-176

Exclusivity Expiration Date : 2025-04-18

Application Number : 208065

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

OSIMERTINIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-941

Exclusivity Expiration Date

2027-02-16

Application Number

208065

Product Number

2

Exclusivity Details

03

ASTRAZENECA

OSIMERTINIB MESYLATE

Fi Europe 2024

Not Confirmed

ASTRAZENECA

United Kingdom

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

OSIMERTINIB MESYLATE

Exclusivity Code : I-941

Exclusivity Expiration Date : 2027-02-16

Application Number : 208065

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

OSIMERTINIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-337

Exclusivity Expiration Date

2027-12-18

Application Number

208065

Product Number

2

Exclusivity Details

04

ASTRAZENECA

OSIMERTINIB MESYLATE

Fi Europe 2024

Not Confirmed

ASTRAZENECA

United Kingdom

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

OSIMERTINIB MESYLATE

Exclusivity Code : ODE-337

Exclusivity Expiration Date : 2027-12-18

Application Number : 208065

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

OSIMERTINIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-176

Exclusivity Expiration Date

2025-04-18

Application Number

208065

Product Number

2

Exclusivity Details

05

ASTRAZENECA

OSIMERTINIB MESYLATE

Fi Europe 2024

Not Confirmed

ASTRAZENECA

United Kingdom

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

OSIMERTINIB MESYLATE

Exclusivity Code : ODE-176

Exclusivity Expiration Date : 2025-04-18

Application Number : 208065

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

OSIMERTINIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-941

Exclusivity Expiration Date

2027-02-16

Application Number

208065

Product Number

1

Exclusivity Details

06

ASTRAZENECA

OSIMERTINIB MESYLATE

Fi Europe 2024

Not Confirmed

ASTRAZENECA

United Kingdom

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

OSIMERTINIB MESYLATE

Exclusivity Code : I-941

Exclusivity Expiration Date : 2027-02-16

Application Number : 208065

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?